[Urographic investigations on the effect of high dose progestagen therapy (author's transl)].
The relationship between high dose progestagen treatment and changes on the intravenous urogram were studied in 27 patients. For this purpose, six specific features in the urogram were examined. Our findings in the patients available to use indicate that there is no demonstrable dilatation of the renal pelves and ureters as a result of the administration of progestational substances alone. These results are discussed in relation to the relevant literature.
D004108:Dilatation, Pathologic / Q000139:chemically induced; D005260:Female; D006801:Humans; D007682:Kidney Pelvis / Q000000981:diagnostic imaging / Q000187:drug effects; D008134:Long-Term Care; D009640:Norethindrone / Q000008:administration & dosage; D045167:Progesterone Congeners / Q000008:administration & dosage*; D011859:Radiography; D014513:Ureter / Q000000981:diagnostic imaging / Q000187:drug effects*
D045167:Progesterone Congeners; D009640:Norethindrone
Urographische Untersuchungen zur Wirkung einer hochdosierten Progestagentherapie